Recalls / Active ingredient / Regadenoson
Regadenoson
1 FDA drug recall involving the active ingredient “Regadenoson”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2024-10-30 | Class II | Regadenoson Injection, 0.4 mg/5 mL (0.08 mg/mL), 5mL Single-Dose Pre-filled Syringe, Rx only, Manufactured by: | Baxter Healthcare Corporation |